Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hemostatic Disorders 1Agnosia 1

Interventions

Bupivacaine 11Ketamine 9Ropivacaine 8Morphine 8Analgesics, Opioid 8Acetaminophen 8Fentanyl 7Dexmedetomidine 7Lidocaine 6Anesthesia, General 6Saline Solution 5Anesthesia, Local 5Acupuncture Therapy 5parecoxib 4Tramadol 4Surveys and Questionnaires 4Sodium Chloride 4Pregabalin 4Ethanol 4Analgesia, Epidural 4Transcutaneous Electric Nerve Stimulation 3Radiofrequency Ablation 3Propofol 3Oxycodone 3Ketorolac 3Control Groups 3Anesthetics, Local 3trimebutine 3-thiocarbamoylbenzenesulfonate 2Therapeutics 2Tea 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Agnosia × Dipyrone × Clear all
NCT07384013 2026-02-03

Study Protocol: Impact of Metamizole (OptalginĀ®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Rambam Health Care Campus

Phase NA Recruiting
30 enrolled

Agnosia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚔